• DOI:10.1002/mus.10300
• Corpus ID: 10373463

Choline acetyltransferase mutations in myasthenic syndrome due to deficient acetylcholine resynthesis

@article{Maselli2003CholineAM,
  title={Choline acetyltransferase mutations in myasthenic syndrome due to deficient acetylcholine resynthesis},
  author={Ricardo A Maselli and Da Guang Chen and Delores Mo and Constance M. Bowe and Grace Fenton and Robert L. Wollmann},
  journal={Muscle \& Nerve},
  year={2003},
  volume={27}
}

• R. Maselli, D. Chen, +3 authors R. Wollmann
• Published 1 February 2003
• Medicine, Biology
• Muscle & Nerve

The myasthenic syndrome due to abnormal acetylcholine resynthesis is characterized by early onset, recessive inheritance, and recurrent episodes of potentially fatal apnea. Mutations in the gene encoding choline acetyltransferase (CHAT) have been found to account for this condition. We have identified five patients from three independent families with features of this disease including, in four patients, a paradoxical worsening of symptoms with cold temperatures. Electrodiagnostic studies demonstrated impaired neuromuscular transmission in all patients. In vitro microelectrode studies performed in the anconeus muscle biopsies of two patients showed moderate reduction of quantal release. Electron microscopy of the neuromuscular junction was normal in both patients. Each patient had two heterozygous CHAT mutations including L210P and P211A (family 1), V194L and V506L (family 2), and R548stop and S694C (family 3). Three of these mutations have previously been reported and suggest that, in this syndrome, some molecular defects may be more prevalent than others. Muscle Nerve 27: 180–187, 2003